Reply to Masters: Recombinant coronavirus balances biosafety and benefit.

Proc Natl Acad Sci U S A

Cellular Biology Section, Laboratory of Viral Diseases, Division of Intramural Research, National Institute for Allergy and infectious Diseases, Bethesda, MD 20892.

Published: October 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11536162PMC
http://dx.doi.org/10.1073/pnas.2416109121DOI Listing

Publication Analysis

Top Keywords

reply masters
4
masters recombinant
4
recombinant coronavirus
4
coronavirus balances
4
balances biosafety
4
biosafety benefit
4
reply
1
recombinant
1
coronavirus
1
balances
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!